Biotech

All Articles

8 months after a $213M fundraise, genetics publisher Volume creates reduces

.After increasing $213 million in 2023-- among the year's biggest personal biotech rounds-- Tome Bio...

BioMarin creates exec crew with biotech vets-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as wel...

Biopharma Q2 VC hit highest level considering that '22, while M&ampA reduced

.Equity capital backing in to biopharma cheered $9.2 billion throughout 215 handle the 2nd fourth of...

Bicara, Zenas look for IPOs to push late-phase assets toward market

.Bicara Therapeutics and also Zenas Biopharma have actually given new inspiration to the IPO market ...

Genentech to shut cancer cells immunology analysis department

.Genentech is going to shut its own cancer cells immunology analysis team, as well as unit head as w...

Kezar loses solid growth yet to prove its really worth in stage 1 trial

.Kezar Life Sciences is losing its own unpromising stage 1 strong growth medicine as the biotech goe...

Acelyrin loses izokibep, drops 3rd of workers

.Regardless of izokibep keeping its own newly found winning touch in the clinic, Acelyrin is no long...

Rivus' phase 2 obesity-related heart failure trial hits endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its own fat-busting, muscle-sparing medicine ...

Ovid standstills preclinical job, IV course after soticlestat fall short

.Ovid Rehab currently disclosed final month that it was actually trimming back its head count as the...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has actually opened a $700 thousand R&ampD facility in the Boston ma Port, increasing its...